A.I. Burnasyan Scientific journal FMBC

Clinical Bulletin

ISSN 2782-6430 (print)

State Research Center −Burnasyan Federal Medical Biophysical
Center of Federal Medical Biological Agency

The journal is published in Russian.
Format – A4.
The periodicity of the journal is 4 times a year.

Issue №1 2024 год

more

A.I. Burnasyan  FMBC clinical bulletin. 2022 № 2

Features of the Activity of Biological Banks: World Practice
T.A. Astrelina, A.S. Samoilov

A.I. Burnasyan Federal Medical Biophysical Center, Moscow, Russia
Contact person: Tatiana Astrelina, t_astrelina@mail.ru

Abstract
The features and problems of the development of biological banks are presented. Biological banks (Biobanks) play an important role in obtaining information and are a key link in diagnostics in the identification of new biomarkers of diseases, the development of prognostic tests and treatment – the creation of new targeted drugs for cancer and therapy. In the developing world, the role of biobanks is constantly increasing. The capabilities of biobanks make it possible to conduct a large-scale scientific analysis, to benefit the scientific community, the health of patients, and donors in the form of information about the diagnosis, prognosis, recommendations for the prevention and treatment of diseases. The continuous development of biobanks is supported by many years of experience and serves as a guide for the creation of new biobanks. Local government and the legal system must be ready for the development of biobanks. The interdisciplinary nature of biobanks contributes to the development of biomedical research and clinical practice.

Keywords: biobanks, biomedicine, personalized medicine, technologies

For citation: Astrelina T.A., Samoilov A.S. Features of the Activity of Biological Banks: World Practice . A.I. Burnasyan Federal Medical Biophysical Center Clinical Bulletin. 2022.2:45-48. (In Russian) DOI: 10.33266/2782-6430-2022-2-45-48

REFERENCES

  1. Wiktor Paskal, Adriana M. Paska, Tomasz, Maciej Gryziak, Janusz Jaworowski. Aspects of Modern Biobank Activity – Comprehensive Review. Pathology & Oncology Research. 2018;24:771–778.
  2. Luigi Coppola, Alessandra Cianflone, Anna Maria Grimaldi, Mariarosaria Incoronato, Paolo Bevilacqua , Francesco Messina, Simona Baselice, Andrea Soricelli, Peppino Mirabelli, Marco Salvatore. Biobanking in Health Care: Evolution and Future Directions. J. Transl. Med. 2019;17:172.
  3. Loes Linsen, Veronique T’Joen, Catherine Van Der Straeten, Kristel Van Landuyt, Etienne Marbaix, Sofie Bekaert, Nadine Ectors. Biobank Quality Management in the BBMRI.be Network. Front. Med. 2019;6:141-150. doi: 10.3389/fmed.2019.00141.
  4. Anna Beskow. Uppsala Biobank—the Development of a Biobank Organization in a Local, Regional, and National Setting. UPSALA Journal of Medical Sciences. 2019;124;1:6–8. https://doi.org/10.1080/03009734.2018.1547992.
  5. Loft S., Poulsen H.E. Cancer Risk and Oxidative DNA Damage in Man. J. Mol. Med. (Berlin, Germany). 1996;74:297–312.
  6. Carey D.J., Fetterolf S.N., Davis D., Faucett W.A, Kirchner H.L., Mirshahi U., Murray M.F., Smelser D.T., Gerhard G.S., Ledbetter D.H. The Geisinger MyCode Community Health Initiative: an Electronic Health Record-Linked Biobank for Precision Medicine Research. Genet. Med. 2016;18:906–913.
  7. Liu A.G., Pollard K. Biobanking for Personalized Medicine. Advances in Experimental Medicine and Biology. 2015;864:55–68.
  8. Hewitt R., Watson P. Defining Biobank. Biopreserv Biobank. 2013;11;5:309–315.
  9. Zika E., Paci D., Braun A., Rijkers-Defrasne S., Deschenes M., Fortier I., Laage-Hellman J., Scerri C.A., Ibarreta D. A. European Survey on Biobanks: Trends and Issues. Public Health Genomics. 2011;14;2:96–103.
  10. Takai-Igarashi T., Kinoshita K., Nagasaki M., Ogishima S., Nakamura N., Nagase S., Nagaie S., Saito T., Nagami F., Minegishi N., et al. Security Controls in an Integrated Biobank to Protect Privacy in Data Sharing: Rationale and Study Design. BMC Med. Inform. Decis Mak. 2017;17:100.
  11. Hubel A., Spindler R., Skubitz A.P.N. Storage of Human Biospecimens: Selection of the Optimal Storage Temperature. Biopreserv Biobank. 2014;12:165–175.
  12. Mauffrey C., Giannoudis P., Civil I, Gray A.C., Roberts C., Pape H.C., Evans C., Kool B., Mauffrey O.J., Stengel D. Pearls and Pitfalls of Open Access: the Immortal Life of Henrietta Lacks. Injury Int. J. Care Injured. 2017;48:1–2.
  13. Turner T. Development of the Polio Vaccine: a Historical Perspective of Tuskegee University’s Role in Mass Production and Distribution of HeLa Cells. J. Health Care Poor Underserved. 2012;23:5–10.
  14. Corral-Vazquez C., Aguilar-Quesada R., Catalina P., Lucena-Aguilar G., Ligero G., Miranda B., Carrillo-Avila J.A.. Cell Lines Authentication and Mycoplasma Detection as Minimun Quality Control of Cell Lines in Biobanking. Cell Tissue Bank. 2017;18:271–280.
  15. De Souza Y.G., Greenspan J.S. Biobanking Past, Present and Future: Responsibilities and Benefits. Aids. 2013;27:303–312.
  16. Keis A. Biobanking in Estonia. J. Law Med Ethics. 2016;44:20–23.
  17. Fischer K., Kettunen J., Wurtz P., Haller T., Havulinna A.S., Kangas A.J., Soininen P., Esko T., Tammesoo M.L., Magi R., et al. Biomarker Profiling by Nuclear Magnetic Resonance Spectroscopy for the Prediction of All-Cause Mortality: an Observational Study of 17,345 Persons. PLoS Med. 2014;11:e1001606.
  18. Sudlow C., Gallacher J., Allen N., Beral V., Burton P., Danesh J., Downey P., Elliott P., Green J., Landray M., et al. UK Biobank: an Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age. PLoS Med. 2015;12:e1001779.
  19. Rose R., Nolan D.J., Maidji E., Stoddart C.A., Singer E.J., Lamers S.L., McGrath M.S. Eradication of HIV from Tissue Reservoirs: Challenges for the Cure. AIDS Res. Hum. Retroviruses. 2018;34:3–8.
  20. Van Draanen J., Davidson P., Bour-Jordan H., Bowman-Carpio L., Boyle D., Dubinett S., Gardner B., Gardner J., McFall C., Mercola D., et al. Assessing Researcher Needs for a Virtual Biobank. Biopreserv Biobank. 2017;15:203–210.
  21. Capocasa M., Anagnostou P., D’Abramo F., Matteucci G., Dominici V., Bisol G.D., Rufo F. Samples and Data Accessibility in Research Biobanks: an Explorative Survey. PeerJ. 2016;4:e1613.
  22. Ransohoff D.F., Gourlay M.L. Sources of Bias in Specimens for Research about Molecular Markers for Cancer. J. Clin. Oncol. 2010;28:698–704.
  23. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neu Oncogene. Science (New York, NY). 1987;235:177–182.
  24. Weinstein J.N., Collisson E.A., Mills G.B., Shaw K.R.M., Ozenberger B.A., Ellrott K., Shmulevich I., Sander C., Stuart J.M. Canc Genome Atlas Res N: the Cancer Genome Atlas Pan-Cancer Analysis Project. Nat. Genet. 2013;45:1113–1120.
  25. Olson J.E., Bielinski S.J., Ryu E., Winkler E.M., Takahashi P.Y., Pathak J., Cerhan J.R. Biobanks and Personalized Medicine. Clin Genet. 2014;86:50–55.
  26. Paskal W., Paskal A.M., Debski T., Gryziak M., Jaworowski J. Aspects of Modern Biobank Activity—Comprehensive Review. Pathol. Oncol. Res. 2018;24:771–785.
  27. Pedersen O.B., Erikstrup C., Kotze S.R., Sorensen E., Petersen M.S., Grau K., Ullum H. The Danish Blood Donor Study: a Large, Prospective Cohort and Biobank for Medical Research. Vox Sang. 2012;102:271–271.
  28. Litton J.E. Launch of an Infrastructure for Health Research: BBMRI-ERIC. Biopreserv Biobank. 2018;16:233–241.
  29. Mayrhofer M.T., Holub P., Wutte A., Litton J.E. BBMRI-ERIC: the Novel Gateway to Biobanks from Humans to Humans. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2016;59:379–384.
  30. Peakman T., Elliott P. Current Standards for the Storage of Human Samples in Biobanks. Genome Med. 2010;2:72.
  31. Mastroleo I. Post-Trial Obligations in the Declaration of Helsinki 2013: Classification, Reconstruction and Interpretation. Dev World Bioethics. 2016;16:80–90.
  32. Cervo S., De Paoli P., Mestroni E., Perin T., Escoffier L., Canzonieri V., Steffan A. Drafting Biological Material Transfer Agreement: a Ready-to-Sign Model for Biobanks and Biorepositories. Int. J. Biol. Markers. 2016;31:E211–E217.
  33. On Approval of Requirements for the Organization and Operation of Biobanks and Rules for the Storage of Biological Material, Cells for the Preparation of Cell Lines, Cell Lines Intended for the Production of Biomedical Cell Products, Biomedical Cell Products. Order of the Ministry of Health of Russia Dated October 20, 2017, No. 842n. (In Russ.). [Об утверждении требований к организации и деятельности биобанков и правил хранения биологического материала, клеток для приготовления клеточных линий, клеточных линий, предназначенных для производства биомедицинских клеточных продуктов, биомедицинских клеточных продуктов: Приказ Минздрава России от 20.10.2017 № 842н].
  34. On Approval of the Procedure for Providing Medical Care for Diseases (conditions) for the Treatment of Which Transplantation (Transplantation) of Bone Marrow and Hematopoietic Stem Cells is Used and Amending the Procedure for Providing Medical Care in the Profile of Surgery (Transplantation of Human Organs and (or) Tissues). Order of the Ministry of Health of Russia Dated December 12, 2018, No. 875n. (In Russ.). [Об утверждении порядка оказания медицинской помощи при заболеваниях (состояниях), для лечения которых применяется трансплантация (пересадка) костного мозга и гемопоэтических стволовых клеток и внесении изменения в Порядок оказания медицинской помощи по профилю хирургия (трансплантация органов и (или) тканей человека): Приказ Минздрава России от 12.12.2018 г. № 875н].
  35. Howard H.C., Mascalzoni D., Mabile L., Houeland G., Rial-Sebbag E., Cambon-Thomsen A. How to Responsibly Acknowledge Research Work in the Era of Big Data and Biobanks: Ethical Aspects of the Bioresource Research Impact Factor (BRIF). J. Community Genet. 2018;9:169–176.
  36. Mate S., Kadioglu D., Majeed R.W., Stohr M.R., Folz M., Vormstein P., Storf H., Brucker D.P., Keune D., Zerbe N., et al. Proof-of-Concept Integration of Heterogeneous Biobank IT Infrastructures Into a Hybrid Biobanking Network. German Med Data Sci Vis Bridges. 2017;243:100–104.
  37. Neri E., Regge D. Imaging Biobanks in Oncology: European Perspective. Future Oncol. 2017;13:433–441.
  38. Aiello M., Cavaliere C., D’Albore A., Salvatore M. The Challenges of Diagnostic Imaging in the Era of Big Data. J. Clin. Med. 2019;8:316.
  39. European Soc R. ESR POSITION PAPER ON IMAGING BIOBANks. Insights into Imaging. 2015;6:403–410.
  40. Marti Bonmati L., Alberich-Bayarri A., Garcia-Marti G., Sanz Requena R., Perez Castillo C., Carot Sierra J.M., Manjon Herrera J.V. Imaging Biomarkers, Quantitative Imaging, and Bioengineering. Radiologia. 2012;54:269–278.
  41. Langhof H., Kahrass H., Illig T., Jahns R., Strech D. Current Practices for Access, Compensation, and Prioritization in Biobanks. Results from an Interview Study. Eur. J. Hum. Genet. 2018;26:1572–1581.
  42. Incoronato M., Aiello M., Infante T., Cavaliere C., Grimaldi A.M., Mirabelli P., Monti S., Salvatore M. Radiogenomic Analysis of Oncological Data: a Technical Survey. Int. J. Mol. Sci. 2017;18:805.
  43. Lisanti M.P., Tanowitz H.B. Translational Discoveries, Personalized Medicine, and Living Biobanks of the Future. Am. J. Pathol. 2012;180;4:1334–1336. https://doi.org/10.1016/j.ajpath.2012.02.003.
  44. Van Ommen G.J., Tornwall O., Brechot C., Dagher G., Galli J., Hveem K., et al. BBMRI-ERIC as a Resource for Pharmaceutical and Life Science Industries: the Development of Biobank-Based Expert Centres. Eur. J. Hum. Gen: EJHG. 2015;23;7:893-900. https://doi.org/10.1038/ejhg.2014.235.
  45. Womack C., Mager S.R. Human Biological Sample Biobanking to Support Tissue Biomarkers in Pharmaceutical Research and Development. Methods (San Diego, Calif). 2014;70;1:3–11. https://doi.org/10.1016/j.ymeth.2014.01.014.

Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.01.2022. Accepted for publication: 01.02.2022

© 2024 Scientific journal - "Clinical Bulletin of the FMBС im. A.I. Burnasyan"
Scroll to Top